The global market for Respiratory Disease Testing is estimated at US$3.2 Billion in 2023 and is projected to reach US$4.2 Billion by 2030, growing at a CAGR of 4% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. ![Respiratory Disease Testing Market]( "Respiratory Disease Testing Market")
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Imaging Test segment, which is expected to reach US$1.4 Billion by 2030 with a CAGR of a 4.5%. The Lung Volume Test segment is also set to grow at 3.9% CAGR over the next 7 years.
- Regional Analysis: Gain insights into the U.S. market, estimated at $868.2 Million in 2023, and China, forecasted to grow at an impressive 6.3% CAGR to reach $873.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Respiratory Disease Testing Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Respiratory Disease Testing Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Respiratory Disease Testing Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Abbott Laboratories, Affymetrix, Inc., Alere, Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 12 Featured):
- Abbott Laboratories
- Affymetrix, Inc.
- Alere, Inc.
- CareFusion Corporation
- Carestream Health, Inc.
- Cepheid, Inc.
- Cosmed Srl
- F. Hoffmann-La Roche AG
- GE Healthcare
- Medtronic PLC
- MGC Diagnostics Corporation
- ndd Medizintechnik AG
- Nihon Kohden Corporation
- PerkinElmer, Inc.
- Philips Healthcare
- SDI Diagnostics
- Seegene, Inc.
- Siemens Healthineers
- Smiths Medical
MarketGlass Platform
Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Respiratory Disease Testing - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- Global Economic Update
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 2: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 3: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 4: World Recent Past, Current & Future Analysis for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 5: World Historic Review for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 6: World 16-Year Perspective for Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Physician Offices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 8: World Historic Review for Physician Offices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 9: World 16-Year Perspective for Physician Offices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 10: World Respiratory Disease Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- Table 11: World Recent Past, Current & Future Analysis for Respiratory Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 12: World Historic Review for Respiratory Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 13: World 16-Year Perspective for Respiratory Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
- Table 14: World Recent Past, Current & Future Analysis for Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 15: World Historic Review for Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 16: World 16-Year Perspective for Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 17: World Recent Past, Current & Future Analysis for Lung Volume by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 18: World Historic Review for Lung Volume by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 19: World 16-Year Perspective for Lung Volume by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 20: World Recent Past, Current & Future Analysis for Spirometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 21: World Historic Review for Spirometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 22: World 16-Year Perspective for Spirometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 23: World Recent Past, Current & Future Analysis for Peak Flow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 24: World Historic Review for Peak Flow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 25: World 16-Year Perspective for Peak Flow by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 26: World Recent Past, Current & Future Analysis for Blood Gas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 27: World Historic Review for Blood Gas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 28: World 16-Year Perspective for Blood Gas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 29: World Recent Past, Current & Future Analysis for Other Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 30: World Historic Review for Other Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 31: World 16-Year Perspective for Other Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
UNITED STATES
- Respiratory Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- Table 32: USA Recent Past, Current & Future Analysis for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 33: USA Historic Review for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 34: USA 16-Year Perspective for Respiratory Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Physician Offices and Clinical Laboratories for the Years 2014, 2024 & 2030
- Table 35: USA Recent Past, Current & Future Analysis for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 36: USA Historic Review for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 37: USA 16-Year Perspective for Respiratory Disease Testing by Test - Percentage Breakdown of Value Sales for Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests for the Years 2014, 2024 & 2030
CANADA
- Table 38: Canada Recent Past, Current & Future Analysis for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 39: Canada Historic Review for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 40: Canada 16-Year Perspective for Respiratory Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Physician Offices and Clinical Laboratories for the Years 2014, 2024 & 2030
- Table 41: Canada Recent Past, Current & Future Analysis for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 42: Canada Historic Review for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 43: Canada 16-Year Perspective for Respiratory Disease Testing by Test - Percentage Breakdown of Value Sales for Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests for the Years 2014, 2024 & 2030
JAPAN
- Respiratory Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- Table 44: Japan Recent Past, Current & Future Analysis for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 45: Japan Historic Review for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 46: Japan 16-Year Perspective for Respiratory Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Physician Offices and Clinical Laboratories for the Years 2014, 2024 & 2030
- Table 47: Japan Recent Past, Current & Future Analysis for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 48: Japan Historic Review for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 49: Japan 16-Year Perspective for Respiratory Disease Testing by Test - Percentage Breakdown of Value Sales for Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests for the Years 2014, 2024 & 2030
CHINA
- Respiratory Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- Table 50: China Recent Past, Current & Future Analysis for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 51: China Historic Review for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 52: China 16-Year Perspective for Respiratory Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Physician Offices and Clinical Laboratories for the Years 2014, 2024 & 2030
- Table 53: China Recent Past, Current & Future Analysis for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 54: China Historic Review for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 55: China 16-Year Perspective for Respiratory Disease Testing by Test - Percentage Breakdown of Value Sales for Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests for the Years 2014, 2024 & 2030
EUROPE
- Respiratory Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- Table 56: Europe Recent Past, Current & Future Analysis for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 57: Europe Historic Review for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 58: Europe 16-Year Perspective for Respiratory Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Physician Offices and Clinical Laboratories for the Years 2014, 2024 & 2030
- Table 59: Europe Recent Past, Current & Future Analysis for Respiratory Disease Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 60: Europe Historic Review for Respiratory Disease Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 61: Europe 16-Year Perspective for Respiratory Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
- Table 62: Europe Recent Past, Current & Future Analysis for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 63: Europe Historic Review for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 64: Europe 16-Year Perspective for Respiratory Disease Testing by Test - Percentage Breakdown of Value Sales for Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests for the Years 2014, 2024 & 2030
FRANCE
- Respiratory Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- Table 65: France Recent Past, Current & Future Analysis for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 66: France Historic Review for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 67: France 16-Year Perspective for Respiratory Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Physician Offices and Clinical Laboratories for the Years 2014, 2024 & 2030
- Table 68: France Recent Past, Current & Future Analysis for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 69: France Historic Review for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 70: France 16-Year Perspective for Respiratory Disease Testing by Test - Percentage Breakdown of Value Sales for Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests for the Years 2014, 2024 & 2030
GERMANY
- Respiratory Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- Table 71: Germany Recent Past, Current & Future Analysis for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 72: Germany Historic Review for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 73: Germany 16-Year Perspective for Respiratory Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Physician Offices and Clinical Laboratories for the Years 2014, 2024 & 2030
- Table 74: Germany Recent Past, Current & Future Analysis for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 75: Germany Historic Review for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 76: Germany 16-Year Perspective for Respiratory Disease Testing by Test - Percentage Breakdown of Value Sales for Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests for the Years 2014, 2024 & 2030
ITALY
- Table 77: Italy Recent Past, Current & Future Analysis for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 78: Italy Historic Review for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 79: Italy 16-Year Perspective for Respiratory Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Physician Offices and Clinical Laboratories for the Years 2014, 2024 & 2030
- Table 80: Italy Recent Past, Current & Future Analysis for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 81: Italy Historic Review for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 82: Italy 16-Year Perspective for Respiratory Disease Testing by Test - Percentage Breakdown of Value Sales for Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Respiratory Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- Table 83: UK Recent Past, Current & Future Analysis for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 84: UK Historic Review for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 85: UK 16-Year Perspective for Respiratory Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Physician Offices and Clinical Laboratories for the Years 2014, 2024 & 2030
- Table 86: UK Recent Past, Current & Future Analysis for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 87: UK Historic Review for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 88: UK 16-Year Perspective for Respiratory Disease Testing by Test - Percentage Breakdown of Value Sales for Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests for the Years 2014, 2024 & 2030
SPAIN
- Table 89: Spain Recent Past, Current & Future Analysis for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 90: Spain Historic Review for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 91: Spain 16-Year Perspective for Respiratory Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Physician Offices and Clinical Laboratories for the Years 2014, 2024 & 2030
- Table 92: Spain Recent Past, Current & Future Analysis for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 93: Spain Historic Review for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 94: Spain 16-Year Perspective for Respiratory Disease Testing by Test - Percentage Breakdown of Value Sales for Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests for the Years 2014, 2024 & 2030
RUSSIA
- Table 95: Russia Recent Past, Current & Future Analysis for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 96: Russia Historic Review for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 97: Russia 16-Year Perspective for Respiratory Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Physician Offices and Clinical Laboratories for the Years 2014, 2024 & 2030
- Table 98: Russia Recent Past, Current & Future Analysis for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 99: Russia Historic Review for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 100: Russia 16-Year Perspective for Respiratory Disease Testing by Test - Percentage Breakdown of Value Sales for Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests for the Years 2014, 2024 & 2030
REST OF EUROPE
- Table 101: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 102: Rest of Europe Historic Review for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 103: Rest of Europe 16-Year Perspective for Respiratory Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Physician Offices and Clinical Laboratories for the Years 2014, 2024 & 2030
- Table 104: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 105: Rest of Europe Historic Review for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 106: Rest of Europe 16-Year Perspective for Respiratory Disease Testing by Test - Percentage Breakdown of Value Sales for Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Respiratory Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- Table 107: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 108: Asia-Pacific Historic Review for Respiratory Disease Testing by End-Use - Hospitals, Physician Offices and Clinical Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 109: Asia-Pacific 16-Year Perspective for Respiratory Disease Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Physician Offices and Clinical Laboratories for the Years 2014, 2024 & 2030
- Table 110: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Disease Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 111: Asia-Pacific Historic Review for Respiratory Disease Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 112: Asia-Pacific 16-Year Perspective for Respiratory Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
- Table 113: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 114: Asia-Pacific Historic Review for Respiratory Disease Testing by Test - Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 115: Asia-Pacific 16-Year Perspective for Respiratory Disease Testing by Test - Percentage Breakdown of Value Sales for Imaging, Lung Volume, Spirometry, Peak Flow, Blood Gas and Other Tests for the Years 2014, 2024 & 2030
AUSTRALIA
- Respiratory Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
- Respiratory Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
LATIN AMERICA
- Respiratory Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
MIDDLE EAST
- Respiratory Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
AFRICA
- Respiratory Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
Companies Mentioned
- Abbott Laboratories
- Affymetrix, Inc.
- Alere, Inc.
- CareFusion Corporation
- Carestream Health, Inc.
- Cepheid, Inc.
- Cosmed Srl
- F. Hoffmann-La Roche AG
- GE Healthcare
- Medtronic PLC
- MGC Diagnostics Corporation
- ndd Medizintechnik AG
- Nihon Kohden Corporation
- PerkinElmer, Inc.
- Philips Healthcare
- SDI Diagnostics
- Seegene, Inc.
- Siemens Healthineers
- Smiths Medical
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 158 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 3.2 Billion |
| Forecasted Market Value ( USD | $ 4.2 Billion |
| Compound Annual Growth Rate | 4.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 19 |
